Background: Acinetobacter baumannii resistance islands (AbaRs) have been recently recognized as mobile genetic elements that harbor multiple resistance determinants and are associated with multidrug resistance (MDR). In the present study, we aimed to determine the AbaRs conferring multiple antimicrobial resistance and their clonal relatedness to MDR A. baumannii clinical isolates obtained from a university hospital in Daejeon, Korea.
INTRODUCTION
Acinetobacter baumannii is an aerobic, glucose-nonfermenting, Gram-negative bacterium that has recently emerged as a serious opportunistic and nosocomial pathogen [1] . A few lineages of multidrug-resistant (MDR) A. baumannii strains, which are resistant to all or most clinically relevant antimicrobial agents, have been reported worldwide and have caused multiple hospital outbreaks. In particular, 2 of these lineages, European (EU) clones I and II, have become widespread worldwide [2] .
It has been suggested that MDR A. baumannii strains acquire their antimicrobial resistant genes via resistance islands, integrons, and transposons that carry 1 or more antimicrobial resistance gene cassettes [3] . However, despite extensive research, not much is known about the role of these genetic mobile elements in the evolution of MDR A. baumannii. Recent studies have revealed that some A. baumannii strains harbor multiple antimicrobial resistance regions that are integrated into the comM gene, which encodes an ATPase domain. The first example of these regions, which was found in strain A. baumannii AYE, was designated A. baumannii resistance island (AbaR)1 and harbors 45 genes putatively associated with resistance to antimicrobial agents or biocides. These antimicrobial resistance genes confer resistance to aminoglycosides (kanamycin, genta-http://dx.doi.org/10.3343/alm.2012.32. 5.324 www.annlabmed.org micin, and neomycin), aminocyclitols (spectinomycin and streptomycin), tetracycline, and chloramphenicol [4] .
Following detection of the 86.2-kb AbaR1, 9 additional AbaRs have been fully characterized. All but 1 AbaR (AbaR1, AbaR3, AbaR5, AbaR6, AbaR7, AbaR8, AbaR9, and AbaR10) are found in EU clone 1 strains and have a complex structure, a 16.3-kb backbone transposon (Tn6019) disrupted by a cadmium and zinc resistance gene, and a second transposon (Tn6018) interrupted by a variable assortment of antimicrobial resistance genes. In addition, the blaoxa-23 gene-carrying AbaR4, which is integrated at a chromosomal site other than the comM gene, has been identified in some EU clone I and EU clone II strains [2] . AbaR2 in EU clone II strains consists of a largely truncated AbaR that contains only the right-hand part of an AbaR island and a transposon related to Tn6021. There have been much fewer reports of AbaRs in EU clone II strains.
Although AbaRs have been recently recognized as mobile genetic elements that harbor multiple resistance determinants and are associated with MDR in A. baumannii, there is a relative paucity of data on the number and types of AbaRs in MDR A. baumannii strains isolated from Korea. In the present study, we aimed to determine the AbaRs associated with resistance to multiple antimicrobials and their clonal relatedness to the MDR A. baumannii clinical isolates obtained from a university hospital in Daejeon, Korea.
METHODS

Selection of bacteria isolates
Twenty-two MDR A. baumannii isolates were collected and characterized [5] . Table 1. shows the minimal inhibitory concentrations (MICs) and antimicrobial resistance determinants of the isolates characterized in this study. These isolates were collected from different patients at a single university hospital in Daejeon, Korea during the period between 2007 and 2011. Seven additional strains that were susceptible to carbapenem but resistant to many other antimicrobial agents were also included in this study. Piperacillin, piperacillin/tazobactam, cefepime, ceftazidime, meropenem, and ticarcillin susceptibility testing was performed using the Vitek 2 system (bioMérieux, Marcy l'Eltoile, France). The MICs of imipenem, amikacin, gentamicin, and ciprofloxacin were determined using the Etest (AB Biodisk, Solna, Sweden). Interpretation was performed according to the criteria approved by the CLSI guidelines [6] . Escherichia coli ATCC 25922 was used as a reference strain. Clinical isolates of A. baumannii were identified by rpoB gene analysis and by the presence of the blaoxa-51-like gene [7] .
The MDR phenotype was defined as resistance to representative antimicrobial agents of at least 3 different classes of drugs: aminoglycosides (gentamicin, amikacin), antipseudomonal penicillins (ticarcillin, piperacillin, piperacillin/tazobactam), carbapenems (imipenem, meropenem), antipseudomonal cephalosporins (ceftazidime, cefepime), and fluoroquinolones (ciprofloxacin) [8] .
DNA extraction and PCR amplification
Whole-cell (genomic) DNA was obtained from each target strain using a genomic DNA purification kit (SolGent, Daejeon, Korea) according to the manufacturer's instructions. PCR was performed using 50 ng of genomic DNA, 2.5 µL of 10 5 min. The annealing temperature was 52˚C, unless otherwise specified. The amplified products were separated via electrophoresis on 1.5% (w/v) agarose gels containing ethidium bromide, and visualized using a BioDoc-14TM Imaging system (UVP, Cambridge, UK). For sequencing, PCR products were purified with a PCR purification kit (SolGent) according to the manufacturer's protocols.
Characterization of A. baumannii isolates
The 2 multiplex PCR assays were performed as previously described [9] to identify members of the EU clone I and EU clone II lineages. Epidemiological typing of the isolates was performed by repetitive extragenic palindromic sequence (REP) PCR [10] . The Oxford multilocus sequence typing (MLST) scheme [11] , which uses 7 housekeeping genes (gltA, gyrB, gdhB, recA, cpn60, gpi, and rpoD24) was used to determine the sequence types (STs). A ST number was assigned by comparing the allele sequences to those on the MLST site (http://pubmlst.org/abaumannii/). In addition, class 1 integrons were detected and sequenced using PCR conditions and a primer described previously [5] .
Detection and characterization of AbaRs
The genes associated with the AbaR islands were detected by PCR using published primers ( Table 2 ). The amplified regions are shown in Fig. 1 [4] . To investigate the structure of the AbaR backbone, PCR mapping experiments were performed as described previously [4] . The amplicons were purified and sequenced using a BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 3730XL DNA analyzer (PE Applied Biosystems). DNA fragments (up to 1 kb in size) were sequenced using the overlapping PCR technique. The various DNA sequences were confirmed using the Basic Local Alignment Search Tool (BLAST) program (http:// blast.ncbi.nlm.gov).
RESULTS
Characterization of MDR A. baumannii
The 29 MDR A. baumannii strains were tested to determine their association with the EU clone lineages using multiplex (Fig. 2) . The 2 EU clone I isolates exhibited the type I pattern, while the 27 EU clone II isolates exhibited the type II pattern.
EU clone I strains carry an AbaR-type resistance island
The comM gene was not detected in any of our isolates, but was amplified from the Acinetobacter calcoaceticus control strain. Segments J1 and J2, which form the boundaries of the AbaR backbone transposon Tn6019, were amplified from all 29 isolates (both EU clone I and EU clone II), whereas Tn6018 and an interrupted uspA gene were only present in the EU clone I isolates. These results indicated that an AbaR was only present in the EU clone I isolates. However, it is important to note that J4 (the junction of Tn6018-R with Tn6019) was amplified, but J3 (the junction of Tn6018-L with Tn6019) was not amplified in the EU clone I isolates. In addition, only J6 of the segments J5 and J6 (the junctions of multiple-antibiotic resistance region [MARR] with Tn6018) was amplified in these isolates.
Characterization of the AbaRs
To characterize the AbaRs contained in the EU clone I isolates, we mapped the continuous regions of J1, J2, J4, and J6 by overlapping PCRs and sequencing. The 22-kb AbaR7 (GenBank 
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∆ T n 2 7 6 0 ∆ T n 5 3 9 3 T n 6 0 2 0 T n 6 0 1 8 T n 6 0 1 9 c la s s 1 in t e g r o n t o p A r e s X www.annlabmed.org accession no. GQ406246) was identified in the genome of the MDR A. baumannii isolates that belonged to the EU clone I lineage and were confirmed as ST109 (Fig. 3) . The MARR was located between J1 and J6, and harbored a class 1 integron-containing aacC1-orfP-orfQ-aadA1 gene cassette array. The aacC1 gene conferred resistance to gentamicin, and the aadA1 gene conferred resistance to streptomycin and spectinomycin. The aphA1 gene, the kanamycin and neomycin resistance gene, was flanked by directly oriented copies of IS26.
DISCUSSION
Most EU clone I and EU clone II isolates are resistant to many antimicrobial agents that are currently used for treatment, and are important opportunistic pathogens associated with lifethreatening nosocomial infections and hospital outbreaks. In this study, 27 of 29 MDR A. baumannii strains belonged to the EU clone II lineage and had identical REP-PCR patterns, indicating the clonal relationship and horizontal spread of EU clone II isolates in Daejeon, Korea. These MDR A. baumannii strains have been reported worldwide, including in Korea [9, 12] . In particular, 2 EU clone I isolates (ST109) identified in the present study were isolated in 2007 and 2012. This result suggests that EU clone I isolates (ST109) have existed in Korea for many years even though there have not been any previous reports on the isolation on EU clone I strains in Korea [12] . This is the first report of ST109 A. baumannii strains in Korea. ST109 isolates have been also recovered in Algeria, Argentina, Bulgaria, the UK, and the Netherlands, indicating their global dissemination [13] . In addition, we found a relationship between REP-PCR patterns and isolates that belong to the EU clone I lineage, which contain the blaOXA-69 gene, or the EU clone II lineage, which contain the blaOXA-66 gene.
Two types of class 1 integrons were detected in the MDR A. baumannii isolates in our study. It appeared that the integron with the aacA4-catB8-aadA1 gene cassette array was confirmed in only the EU clone II isolates; however, the integron with the aacC1-orfP-orfQ-aadA1 gene cassette array was detected in only the EU clone I isolates (ST109). In addition, the integron with the aacA4-catB8-aadA1 gene cassette array has been reported in not only A. baumannii, but also in many other bacteria, including Klebsiella pneumoniae, Citrobacter freundii, and Salmonella enterica [14] . In particular, the gene cassette array aacC1-orfP-orfQ-aadA1 is known to be located in AbaR regions and is typical of EU clone I isolates [4] .
The structure of AbaRs was analyzed by a strategy based on the sequence and structural homology of the AbaRs. Although an interrupted comM gene was detected in all EU clone II isolates, the uspA gene was uninterrupted and Tn6018 was not found. Our results suggest that transposon insertion in the EU clone II strains was not closely connected to the Tn6018-containing AbaRs. However, the comM and uspA genes were interrupted and Tn6018 was detected in the EU clone I isolates (ST109), indicating that AbaRs should be present in these strains.
The AbaRs detected in present study were all confirmed as AbaR7 carrying a class 1 integron with the aacC1-orfP-orfQaadA1 gene cassette array. AbaR7 was recovered in an EU clone I strain isolated in Australia in 2005 [4] , but has not yet been detected in A. baumannii isolates from Korea. In the EU clone I isolates (ST109), we found an AbaR7 that lacked a large internal region, including the left portion of Tn6018 and part of the Tn6019 backbone when compared to AbaR3, the original genomic structure of AbaR detected in the EU clone I lineage thus far (Fig. 3) . In contrast to our results, an ST109 isolate was reportedly recovered from the Netherlands in 1984, which harbored AbaR11. These results indicate that the identical type of AbaR may be contained in varied strains of A. baumannii. Diverse AbaRs (8 types) were also detected in ST1 A. baumannii strains isolated from hospitals in the Czech Republic, Italy, and the UK [2] .
AbaRs (except AbaR2) have been previously identified in EU clone I isolates, and we also detected AbaR7 only in EU clone 1 isolates. Although AbaR2 and AbaR4 were recently found in EU clone II isolates [15] [16] [17] , our examination did not show AbaRs in any EU clone II isolates. Consequently, various AbaRs in the EU clone I and EU clone II lineages seem to play a substantial role in antimicrobial resistance in MDR A. baumannii isolates.
In present study, it was found that EU clone I isolates contained AbaR7 with a class 1 integron carrying antimicrobial resistance genes. However, further investigation is required to recover various AbaRs in MDR A. baumannii strains isolated from Korea. The EU clone I (ST109) isolates in this study were resistant to multiple antimicrobial agents, although they were susceptible to carbapenem. This result suggests that EU clone I isolates have been rarely recovered in Korea because previous studies focused mainly on carbapenem resistant or non-susceptible A. baumannii isolates. This finding emphasizes the idea that the antimicrobial resistance mechanisms enabling the development of multidrug resistance should be investigated not only in carbapenem-resistant MDR A. baumannii isolates, but also carbapenem-susceptible isolates.
